Just another Network site

Pfizer just struck a $5.2 billion deal for an eczema drugmaker

Pfizer just struck a $5.2 billion deal for an eczema drugmaker

  • Pfizer just struck a $5.2 billion deal for an eczema drugmaker
  • In April, the drugmaker’s $160 billion megamerger with Allergan was scrapped after the US Treasury released new rules governing so-called tax inversions that undercut the deal’s key rationale.
  • Since then, there have been reports that Pfizer is also interested in cancer drugmaker Medivation .

Read the full article, click here.


@businessinsider: “Pfizer just struck a $5.2 billion deal for an eczema drugmaker”


The acquisition comes about a month after changed Treasury rules blocked Pfizer’s $160 billion megamerger with Allergan


Pfizer just struck a $5.2 billion deal for an eczema drugmaker

Comments are closed, but trackbacks and pingbacks are open.